Latest News


Each news article below shows only part of the news story. To view the full story, click on Read More below the story. 

  • March 01, 2019 8:36 AM | Anonymous

    March 1, 2019, HemOnc Today 

    Sacituzumab govitecan induced durable responses in patients with heavily pretreated metastatic triple-negative breast cancer, according to results of a phase 1/2 single-group trial published in The New England Journal of Medicine. The antibody-drug conjugate also appeared safe among these patients, who achieved better outcomes than those associated with standard chemotherapy for triple-negative disease. 

    Read more.

  • March 01, 2019 8:34 AM | Anonymous

    March 1, 2019, MedPage Today

    When introduced on a nationwide basis, minimally invasive robotic surgery is associated with the performance of a greater proportion of minimally invasive procedures, as well as improved outcomes in patients with early-stage endometrial cancer, Danish investigators found. Specifically, this change in surgical approach leads to a significantly reduced risk of severe complications in these patients.

    Read more.

  • March 01, 2019 8:31 AM | Anonymous

    March 1, 2019, HealthDay News 

    For older adults with a urinary tract infection (UTI), antibiotic treatment should begin immediately to prevent serious complications, a new British study finds. Delaying or withholding antibiotics in this age group can increase the risk of bloodstream infection (sepsis) and death, researchers reported Feb. 27 in the BMJ. 

    Read more

  • February 28, 2019 9:02 AM | Anonymous

    February 28, 2019, MedPage Today  

    Autism was less likely to recur in high-risk families when mothers took prenatal vitamins -- particularly folic acid and perhaps iron as well -- in the first month of their pregnancy, an analysis of MARBLES study data found. 

    Read more.

  • February 27, 2019 1:42 PM | Anonymous

    February 27, 2019, MedPage Today  

    Gonorrhea infection was similar to chlamydia in terms of prior infection increasing risk of subsequent ectopic pregnancy and infertility, Australian researchers found. Compared with women who tested negative for both infections, women who tested positive for gonorrhea only had a higher risk of ectopic pregnancy, while women who tested positive for chlamydia had a similar, slightly higher risk of ectopic pregnancy. 

    Read more.

  • February 27, 2019 1:32 PM | Anonymous

    February 27, 2019, Health Day via Monthly Prescribing Reference 

    Despite claims to the contrary, thermography should not be used in place of mammography for breast cancer screening, detection, or diagnosis, according to the US Food and Drug Administration. 

    Read more.

  • February 26, 2019 3:40 PM | Anonymous

    February 26, 2019, International Continence Society  

    The 49th International Continence Society Annual Meeting will take place on 3-6 September 2019, in Gothenburg, Sweden. This will be a unique experience for all those treating continence and related issues.

    With abstract submission opening March 1, now is the time to take a significant role in the premium meeting in the field. Use the opportunity to:

    ·        Get exposure for your research

    ·        Present alongside the research and practice leaders

    ·        Receive constructive feedback

    ·        Contribute to advancing the treatment of LUTS, incontinence and pelvic floor disorders

    Prepare and submit your abstract by April 1, 2019.

    For more information, visit the ICS 2019 website: https://www.ics.org/2019



  • February 22, 2019 7:10 AM | Anonymous

    February 22, 2019, HealthDay News  

    An experimental drug has shown promise in extending the lives of women suffering from a particularly aggressive and deadly type of breast cancer, according to the results of a phase 2 trial. Right now, the standard treatment of chemotherapy for metastatic triple-negative breast cancer has not been very effective. That might change with the new drug, called sacituzumab govitecan, which combines an antibody with a chemotherapy drug to better target cancer cells.  

    Read more.

  • February 22, 2019 7:05 AM | Anonymous

    February 22, 2019, News Medical 

    New research recently published in the Journal of Clinical Microbiology suggests that the standard test used by the NHS — midstream urine culture (MSU) — may not be reliable enough to exclude a UTI in patients with LUTS. Thousands of women with UTIs experience chronic LUTS that dominates their lives. Despite spending months and years visiting hospitals and GP practices, the tests and treatments they receive still fail to resolve the problem. 

    Read more.

  • February 21, 2019 10:20 AM | Anonymous

    February 21, 2019, MedPage Today 

    The incidence of precancerous cervical lesions containing human papillomavirus (HPV) declined significantly from 2008 to 2014, as did the HPV strains that cause most cervical cancers, CDC investigators reported. 

    Read more.

Powered by Wild Apricot Membership Software